Neil M. Bressler

Active 1982–2025

Also published as
Neil M Bressler
142
Papers
30,765
Citations
92
h-index
138
i10-index

Citations

Citations per year for Neil M. Bressler1976: 1 citations1977: 1 citations1983: 1 citations1984: 1 citations1986: 3 citations1987: 2 citations1988: 4 citations1989: 6 citations1990: 12 citations1991: 11 citations1992: 15 citations1993: 10 citations1994: 21 citations1995: 22 citations1996: 25 citations1997: 35 citations1998: 47 citations1999: 90 citations2000: 69 citations2001: 88 citations2002: 120 citations2003: 111 citations2004: 101 citations2005: 124 citations2006: 133 citations2007: 167 citations2008: 182 citations2009: 146 citations2010: 136 citations2011: 159 citations2012: 180 citations2013: 213 citations2014: 195 citations2015: 257 citations2016: 239 citations2017: 237 citations2018: 401 citations2019: 1,026 citations2020: 1,214 citations2021: 1,131 citations2022: 887 citations2023: 762 citations2024: 923 citations2025: 479 citations2026: 61 citations1978–1982: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,829 citing papers, 25.6% of this breakdownChina: 1,001 citing papers, 9.1% of this breakdownUnited Kingdom: 914 citing papers, 8.3% of this breakdownGermany: 490 citing papers, 4.4% of this breakdownAustralia: 474 citing papers, 4.3% of this breakdownSingapore: 410 citing papers, 3.7% of this breakdownIndia: 382 citing papers, 3.4% of this breakdownItaly: 379 citing papers, 3.4% of this breakdownJapan: 350 citing papers, 3.2% of this breakdownFrance: 306 citing papers, 2.8% of this breakdownSwitzerland: 277 citing papers, 2.5% of this breakdownCanada: 250 citing papers, 2.3% of this breakdown
0%25.6%Other 27%

Fields

  • Medicine85.8%
  • Biochemistry, Genetics and Molecular Biology5.7%
  • Computer Science2.9%
  • Engineering1.2%
  • Neuroscience1.1%
  • Health Professions0.8%
  • Other2.5%

Topics

  • Retinal Diseases and Treatments22.2%
  • Retinal Imaging and Analysis15.1%
  • Glaucoma and retinal disorders6.3%
  • Ophthalmology and Visual Impairment Studies5.4%
  • Retinal and Optic Conditions5.1%
  • Ocular Diseases and Behçet’s Syndrome4.3%
  • Other41.6%

Coauthors

All papers

Open in search
  1. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 2,323

  2. Deep learning in ophthalmology: The technical and clinical considerations

    Authors: , , , , , , , , , , , - Progress in Retinal and Eye Research 2019 cited by 513

  3. Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks

    Authors: , , , , , - JAMA Ophthalmology 2017 cited by 684

  4. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

    Authors: , , , , , , , , , , , - Ophthalmology 2016 cited by 1,031

  5. Addressing Artificial Intelligence Bias in Retinal Diagnostics

    Authors: , , , , - Translational Vision Science & Technology 2021 cited by 132

  6. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2015 cited by 762

  7. An international classification and grading system for age-related maculopathy and age-related macular degeneration

    Authors: , , , , , , , , , , , , , , , - Survey of Ophthalmology 1995 cited by 1,923

  8. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

    Authors: , , , , , , , , , , , , , , - JAMA Ophthalmology 2018 cited by 387

  9. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , - JAMA Ophthalmology 2018 cited by 351

  10. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

    Authors: , , , , , , , - JAMA Ophthalmology 2018 cited by 326

  11. AI for medical imaging goes deep

    Authors: , , , , , - Nature Medicine 2018 cited by 208

  12. Assessment of Deep Generative Models for High-Resolution Synthetic Retinal Image Generation of Age-Related Macular Degeneration

    Authors: , , , , - JAMA Ophthalmology 2019 cited by 170

  13. Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , - Ophthalmology 2010 cited by 1,431

  14. Prevalence of and Risk Factors for Diabetic Macular Edema in the United States

    Authors: , , , , , , , , , , - JAMA Ophthalmology 2014 cited by 423

  15. Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening

    Authors: , - JAMA 2016 cited by 270

  16. Severe Intraocular Inflammation Following Intravitreal Faricimab

    Authors: , , , , , , , - JAMA Ophthalmology 2024 cited by 62

  17. Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .

    Authors: - JAMA 2004 cited by 692

  18. Visual Function Abnormalities and Prognosis in Eyes with Age-related Geographic Atrophy of the Macula and Good Visual Acuity

    Authors: , , , , , , - Ophthalmology 1997 cited by 302

  19. Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , - Ophthalmology 2006 cited by 609

  20. Public Attitudes About Eye and Vision Health

    Authors: , , , , - JAMA Ophthalmology 2016 cited by 222

  21. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment

    Authors: , , , , , - JAMA Ophthalmology 2016 cited by 212

  22. Comparing humans and deep learning performance for grading AMD: A study in using universal deep features and transfer learning for automated AMD analysis

    Authors: , , , , - Computers in Biology and Medicine, Comput. Biol. Medicine 2017 cited by 225

  23. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment

    Authors: , , , , , , , , , , - JAMA Ophthalmology 2016 cited by 212

  24. Low Luminance Visual Dysfunction as a Predictor of Subsequent Visual Acuity Loss from Geographic Atrophy in Age-Related Macular Degeneration

    Authors: , , , , , - Ophthalmology 2008 cited by 190